Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.
dc.contributor.author | Bansal, Arun | en_US |
dc.contributor.author | Singhi, Sunit C | en_US |
dc.contributor.author | Jayashree, M | en_US |
dc.date.accessioned | 2006-04-04 | en_US |
dc.date.accessioned | 2009-05-30T11:44:55Z | |
dc.date.available | 2006-04-04 | en_US |
dc.date.available | 2009-05-30T11:44:55Z | |
dc.date.issued | 2006-04-04 | en_US |
dc.description.abstract | OBJECTIVE: To compare the efficacy of sequential injectable crystalline penicillin (C.pen) and gentamicin combination followed by oral amoxicillin with sequential IV and oral amoxicillin-clavulanate (amox-clav) in treatment of severe or very severe hypoxemic pneumonia. METHODS: Children aged 2-59 months with WHO-defined severe or very severe pneumonia with hypoxemia (SpO2 < 90%) were included in the study. Patients with fever > 10 days, bacterial meningitis, prior antibiotic therapy > 24 hours, stridor, heart disease and allergy to any of the study drugs were excluded. They were randomly allocated to two groups--Group A and Group B. Group A received C. pen and gentamicin intravenously (IV), followed by oral amoxicillin and group B got amox-clav IV, followed by oral amox-clav. Minimum duration of IV therapy was 3 days and total 7 days. Respiratory rate, oxygen saturation and chest wall indrawing were monitored 6 hourly. RESULTS: 71 patients were included. There were two (5.2%) blood cultures positive in group A and three (9%) in group B. Organisms isolated were S. pneumoniae (n=3) and H. influenzae-b (n=2). There was only one treatment failure in each of the groups. One was due to penicillin resistant H. influenzae -b and the other was due to worsening of pneumonia. The mean time taken for normalization of tachypnea, hypoxia, chest wall indrawing and inability to feed was similar (P-N.S). Mean duration of IV therapy in group A was 76+/-25 hrs and group B was 75+/-24 hrs (p>0.1). CONCLUSION: In children of 2-59 months, sequential injectable C. pen and gentamicin combination, followed by oral amoxicillin or sequential IV and oral amox-clav were equally effective for the treatment of severe or very severe hypoxemic community acquired pneumonia. | en_US |
dc.description.affiliation | Department of Pediatrics, Advanced Pediatrics Center, Post Graduate Institute of Medical Education and Research Center, Chandigarh, India. | en_US |
dc.identifier.citation | Bansal A, Singhi SC, Jayashree M. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia. Indian Journal of Pediatrics. 2006 Apr; 73(4): 305-9 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/79990 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://medind.nic.in/icb/icbai.shtml | en_US |
dc.subject.mesh | Administration, Oral | en_US |
dc.subject.mesh | Amoxicillin --administration & dosage | en_US |
dc.subject.mesh | Amoxicillin-Potassium Clavulanate Combination --therapeutic use | en_US |
dc.subject.mesh | Anti-Bacterial Agents --therapeutic use | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Drug Therapy, Combination | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gentamicins --therapeutic use | en_US |
dc.subject.mesh | Haemophilus Infections --drug therapy | en_US |
dc.subject.mesh | Haemophilus influenzae | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Infusions, Intravenous | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Penicillins --therapeutic use | en_US |
dc.subject.mesh | Pneumonia, Bacterial --drug therapy | en_US |
dc.subject.mesh | Pneumonia, Pneumococcal --drug therapy | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia. | en_US |
dc.type | Comparative Study | en_US |
dc.type | Journal Article | en_US |
dc.type | Randomized Controlled Trial | en_US |
Files
License bundle
1 - 1 of 1